PT Kimia Farma (Persero) Tbk – Fresh Garduate, Experienced Kimia Farma February 2019

Share This:

PT Kimia Farma (Persero) Tbk
PT Kimia Farma (Persero) Tbk / kimiafarma.co.id

PT Kimia Farma (Persero) Tbk – Kimia Farma is a major public-listed pharmaceutical company in Indonesia. Kimia Farma is a state-owned company which is majority owned by the Government of Indonesia. Kimia Farma is listed on the Indonesia Stock Exchange (IDX) under reference code KAEF. As today, Kimia Farma is 90.025% owned by the Government of Indonesia which represented by the Minister of State-Owned Enterprises (SOE). Other 0.127% by management/employee and 9.848% by public. Kimia Farma has its business activities focused in pharmaceutical manufacturing, pharmaceutical trade and distribution, retail pharmacy, health clinic, laboratories and optical clinics.

Headquartered in Jakarta, Kimia Farma now has 7 production plant; Plant Jakarta, Plant Bandung, Plant Semarang, Plant Watudakon, Plant Garam Farmasi, Plant Medan, and lant Rapid Test. Kimia Farma also supported by 1 research and development office at Bandung and 1 central logistic unit Jakarta. Kimia Farma also supported 6 directly-owned subsidiaries and affiliated companies, namely PT Kimia Farma Trading & Distribution, PT Kimia Farma Apotek, PT Sinkona Indonesia Lestari, PT Kimia Farma Diagnostik, PT Kimia Farma Sungwun Pharmacopia and PT Asuransi InHealth Indonesia. As of the end of September 2018, Kimia Farma has 1,135 pharmacies, 530 health clinics, 55 clinical laboratories, and 10 optics throughout Indonesia.

According to information found in PT Kimia Farma (Persero) Tbk 2018 Third Quarter Report as quoted by JobsCDC.com, Kimia Farma is running well in the third quarter of 2018 (3Q18, ended in 30 September 2018). Kimia Farma registered total net revenue of Rp5.31 trillion (unaudited) as at the end of September 2018. This reflected an 23.37% increase year-on-year (YOY) as compared with Rp4.30 trillion (unaudited) in the same period previous year. Kimia Farma booked total profit of Rp483.29 billion in the third quarter of 2018 or 45.31% growth YOY as compared with Rp332.60 billion in the third quarter of 2017.
To support the business expansion and its organic growth, PT Kimia Farma (Persero) Tbk invites qualified candidates to fulfill the position as follows

Pharmacist
Major : Pharmacy
 
Pharmacist for DAWAA (Saudi Arabia)
Major : Pharmacy, S2 degree Pharmacy.

Sales & Marketing
Major : S1 degree any major.

Business Development
Major : S1 degree Architect, S2 degree Civil Engineering.

Accounting
Major : S1 degree Accounting.

Information Technology
Major : S1 degree Information System, Information Management.

Legal Officer
Major : S1 degree Law.

Engineering and Production
Major : S1 degree Civil Engineering.

Property
Major : S1 degree Architect, Information Systems.

General Requirements

  • S1 degree in any related major.
  • Maximum age of 27 years old. 
  • Minimum GPA of 3.00 (scale 4.00).
  • Minimum Accreditation B for PTN (all major).
  • Minimum Accreditation A for PTS (all major).
  • Have experience in the same field is an advantage.
  • Fresh graduate are welcome to apply.
  • Energetic, hard worker, high integrity and well groomed.
  • Single/not married.
For further information, please refer official source from PT Kimia Farma (Persero) Tbk on following link below. If you match the profile and are interested in this exiting career opportunity, please apply in confidence by filling online application form at https://bit.ly/opreckaeftw1 (Your application will go directly to Kimia Farma). Closing date 28 February 2019. Application will be treated strictly confidential and only short-listed candidates will receive responses. (JobsCDC.com / Source)

Tidak menemukan informasi Contact? Hubungi Pemasang Iklan >>  http://jobscdc.com